Over two million people so far vaccinated against COVID-19

Over two million people so far vaccinated against COVID-19

Over two million people in South Sudan have been vaccinated against COVID-19, health officials have revealed.

Brendan Dineen, the coordinator of COVAX, applauded the efforts demonstrated by the government to make the vaccines readily available across the 10 states. Dineen revealed that South Sudan had crossed the two million inoculation mark.

The official noted that the vaccine program in the past year has improved, hence increasing access to COVID-19 vaccines.

“In regards to the trend in the vaccine program, the major element has been improving and increasing access to vaccines, and that is something quite notable,” said Dineen.

Dineen revealed that the country had so far reached 2.1 million doses of COVID-19 vaccines, noting that 947, 100 doses of Johnson and Johnson vaccines have recently been received from Portugal and New Zealand.

 “The extent to which the programme has expanded, increasing into communities, has led to a very good uptake under mixed modalities, in health facilities and outreach. We have in total vaccinated 665,237, including 572,996 people fully vaccinated, and 524,262 people have one dose of Johnson and Johnson, “said Dineen.

Anson Edu, WHO Coordinator for COVID-19 vaccination, said the government needs to be cautious, adding that the public health measures should be quickly reinstated if the pandemic worsens.

“We need to be cautious in the manner in which we are easing the preventive measures. A system should be in place to quickly reinstate the measures in an epidemic situation if it worsens, “Edu said.

John Rumunu, the COVID-19 Incident manager at the national Ministry of Health, said the government is monitoring the situation closely and using an evidence-based approach to respond to the pandemic, adding that more still needs to be done to increase the demand for COVID-19 vaccines.

“Regarding the public health measures, “we are using evidence-based information and a risk-based approach. We are monitoring changes in virus and population immunity, but we still need to do more to increase the demand for vaccines,” said Rumunu.